Orpheus Bioscience focuses on the development of treatments for autoimmune diseases. In pursuit of this goal, the company develops the PantId, a protein-based therapeutic for the elimination of pathological immune cells and antibodies from patients. ...Show all
Company (Alive / Active)
9385 Discovery Blvd.
Virginia, United States
|Investor||Investor Type||Location||Participating Rounds|